Peking University Shougang Hospital | ClinicalTrials HQ

6 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Phase 2 Study on the Safety and Efficacy of the Anti-BAFF-R Monoclonal Antibody, ESG206, in Patients With Primary Sjogren Syndrome	Primary Sjögren Syndrome	Not yet recruiting	Phase 2	2026-02-03		NCT07375524
A Study of Telitacicept for IgA Nephropathy (TELIGAN)	Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, IgA glomerulonephritis, Male Urogenital Diseases, Urogenital Diseases, autoimmune disease, glomerulonephritis, immune system disorder, kidney disorder, nephritis, urinary system disorder	Active, not recruiting	Phase 3	2025-12-16		NCT05799287
Comparing the Efficacy and Safety Between Continuous Subcutaneous Beinaglutide and CSII for Newly Diagnosed T2DM Patients	Nutritional and Metabolic Diseases, diabetes mellitus, endocrine system disorder, glucose metabolism disease, metabolic disease, type 2 diabetes mellitus	Recruiting	Not applicable	2025-05-02		NCT03987308
Long-term Efficacy and Safety Study of GV-971	Alzheimer disease, brain disorder, central nervous system disorder, cognitive disorder, dementia, nervous system disorder, neurodegenerative disease, psychiatric disorder, tauopathy	Active, not recruiting	Phase 4	2024-11-15		NCT05181475
The Survey of Treatment and Metabolic Status of Type 1 Diabetes Mellitus (T1DM).	Type1 Diabetes Mellitus	Not yet recruiting	Not stated	2024-09-23		NCT06606509
An Efficacy and Safety Study of Sodium Oligomannate (GV-971) for the Treatment of Alzheimer's Disease	Alzheimer disease, brain disorder, central nervous system disorder, cognitive disorder, dementia, nervous system disorder, neurodegenerative disease, psychiatric disorder, tauopathy	Recruiting	Phase 4	2023-11-09		NCT05908695